在晚期前列腺癌中准瘤细胞表面
Cristina Boixareu1, Tarek Taha1, Varadha Balaji Venkadakrishnan2,3
1The Institute of Cancer Research, The Royal Marsden Hospital, London, UK.
Nature reviews. Urology
|April 1, 2025
概括
准前列腺癌表面酶提供了对抗治疗耐药性的新希望. 研究探索细胞表面蛋白质,如PSMA和B7-H3,用于新型疗法,包括抗体药物合物和CAR T细胞.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 药物开发 药物开发
背景情况:
- 前列腺癌导致全球每年超过375,000人死亡.
- 治疗耐药性是前列腺癌死亡率的主要驱动因素.
- 了解前列腺癌表面的一些进展为治疗提供了新的途径.
研究的目的:
- 探索向前列腺癌表面的治疗潜力.
- 确定关键的细胞表面蛋白质作为晚期前列腺癌的点.
- 对抗性前列腺癌的新兴治疗策略进行审查.
主要方法:
- 前列腺癌表面的特征在治疗耐药的病例中.
- 审查针对细胞表面蛋白的新药开发策略.
- 分析新兴疗法,如抗体药物合物和CAR T细胞.
主要成果:
- 前列腺癌表面组包括PSMA,B7-H3,STEAP1,DLL3,TROP2,PSCA,HER3,CD46和CD36等目标.
- 这些目标的表达异质性可以影响治疗反应和耐药性.
- 几种向疗法正在临床开发中.
结论:
- 利用前列腺癌表面的利用为晚期和耐药性疾病提供了有前途的治疗机会.
- 进一步研究目标生物学,药剂特异性和毒性对于临床实施至关重要.
- 结合策略可能是必要的,以克服目标异质性和阻力.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cell-surface Signaling
51.3K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.3K
Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432


